IKT's three largest insider shareholders as of June 09, 2026 are Capital Life Sciences Pulse Fund Ii, L.P. Sands (TenPercentOwner, 13.02Mn shares), Milton H. Werner (President And Ceo, 5.34Mn shares), Roberto Bellini (Director, 1.46Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Joseph Frattaroli | Chief Financial Officer | 48,091 | 0 | 23 May, 2022 |
| Amit Munshi | - | 0 | 365,000 | 23 Oct, 2024 |
| Vincent Aurentz | - | 510,596 | 0 | 24 Feb, 2026 |
| Roberto Bellini | - | 0 | 1,460,000 | 23 Oct, 2024 |
| Christopher Cabell | President Head Of Rd | 676,564 | 0 | 24 Feb, 2026 |
| Milton H. Werner | President And Ceo | 5,335,433 | 0 | 16 Aug, 2022 |
| Capital Life Sciences Pulse Fund Ii, L.P. Sands | - | 13,018,965 | 0 | 24 Nov, 2025 |
| Arvind Kush | - | 145,000 | 0 | 23 Oct, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 21 Feb, 2026 | Christopher Cabell | Common Stock | D | 338,282 | $0.00 | 676,564 | D | D |
| 21 Feb, 2026 | Amit Munshi | Common Stock | D | 19,089 | $0.00 | 38,176 | D | D |
| 21 Feb, 2026 | Vincent Aurentz | Common Stock | D | 255,299 | $0.00 | 510,596 | D | D |
| 05 Jan, 2026 | Mark T Iwicki | Stock Option (Right to Buy) | A | 4,982,706 | $0.00 | 4,982,706 | D | A |
| 05 Jan, 2026 | Christopher Cabell | Stock Option (Right to Buy) | A | 900,117 | $0.00 | 900,117 | D | A |
| 05 Jan, 2026 | David Mcintyre | Stock Option (Right to Buy) | A | 986,319 | $0.00 | 986,319 | D | A |
| 05 Jan, 2026 | David Mcintyre | Stock Option (Right to Buy) | A | 986,319 | $0.00 | 986,319 | D | A |
| 21 Nov, 2025 | Capital Life Sciences Pulse Fund Ii, L.P. Sands | Common Stock | A | 2,068,965 | $1.45 | 13,018,965 | D | P |
| 21 Nov, 2025 | Capital Life Sciences Pulse Fund Ii, L.P. Sands | Common Stock | A | 2,068,965 | $1.45 | 13,018,965 | D | P |
| 30 Jun, 2025 | Amit Munshi | Stock Option (Right to Buy) | A | 108,176 | $0.00 | 108,176 | D | A |
| 30 Jun, 2025 | Dennis N Berman | Stock Option (Right to Buy) | A | 108,176 | $0.00 | 108,176 | D | A |
| 30 Jun, 2025 | Vincent Aurentz | Stock Option (Right to Buy) | A | 108,176 | $0.00 | 108,176 | D | A |
| 30 Jun, 2025 | Roberto Bellini | Stock Option (Right to Buy) | A | 108,176 | $0.00 | 108,176 | D | A |
| 30 Jun, 2025 | David Canner | Stock Option (Right to Buy) | A | 108,176 | $0.00 | 108,176 | D | A |
| 30 Jun, 2025 | Arvind Kush | Stock Option (Right to Buy) | A | 108,176 | $0.00 | 108,176 | D | A |
| 14 Apr, 2025 | David Mcintyre | Stock Option (Right to Buy) | A | 1,775,539 | $0.00 | 1,775,539 | D | A |
| 14 Apr, 2025 | David Mcintyre | Stock Option (Right to Buy) | A | 1,775,539 | $0.00 | 1,775,539 | D | A |
| 21 Feb, 2025 | Mark T Iwicki | Stock Option (Right to Buy) | A | 602,346 | $0.00 | 602,346 | D | A |
| 21 Feb, 2025 | Vincent Aurentz | Stock Option (Right to Buy) | A | 134,427 | $0.00 | 134,427 | D | A |
| 21 Feb, 2025 | Christopher Cabell | Stock Option (Right to Buy) | A | 1,100,705 | $0.00 | 1,100,705 | D | A |